Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Made Huge Gains on ESRX

Pharmacy benefit management company Express Scripts (ESRX) is trading 9% over yesterday’s close of $35.94. The increase came in spite of the fact that the company lowered its earnings guidance; it is expecting a greater shortfall than expected in claims. Over the last 52 weeks, ESRX has ranged in price from $34.47 a share to $60.89, where it peaked in late May 2011. Several hedge funds made  huge gains on this morning’s increase:

LONE PINE CAPITAL

Stephen Mandel – Lone Pine Capital: Gained $31.9 million

Bain Capital – Brookside Capital: Gained $14.7 million

Steve Cohen – SAC Capital Advisors: Gained $10.7 million

John Lykouretzos – Hoplite Capital Management: Gained $9.7 million

David Stemerman – Conatus Capital Management: Gained $7.5 million

Larry Robbins – Glenview Capital: Gained $7.3 million

Eric Bannasch – Cadian Capital: Gained $7.2 million

These calculations assume that these hedge funds did not increase or reduce their stock positions in ESRX since the end of June. We did not take into account their option positions.

Loading...